Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$62.68 - $95.05 $1,190 - $1,805
-19 Reduced 0.25%
7,464 $700,000
Q4 2022

Feb 06, 2023

SELL
$30.35 - $53.15 $10,136 - $17,752
-334 Reduced 4.27%
7,483 $370,000
Q3 2022

Nov 01, 2022

BUY
$31.97 - $49.37 $3,516 - $5,430
110 Added 1.43%
7,817 $254,000
Q4 2021

Feb 10, 2022

BUY
$72.5 - $100.68 $558,757 - $775,940
7,707 New
7,707 $600,000
Q1 2021

May 12, 2021

SELL
$116.57 - $155.01 $58,285 - $77,505
-500 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$90.37 - $122.49 $9,037 - $12,249
-100 Reduced 16.67%
500 $45,000
Q2 2019

Jul 31, 2019

BUY
$89.51 - $118.04 $53,706 - $70,824
600 New
600 $71,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ropes Wealth Advisors LLC Portfolio

Follow Ropes Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.